Honeywell Aerospace has spun off from Honeywell International Inc. to become an independent public company, now trading on Nasdaq under HONA. The new entity, based in Phoenix with over 36,000 employees, will focus on aerospace and defense systems including avionics, navigation, and engines. Its former parent company, Honeywell Technologies, is now a pure-play automation company.

B. Riley has reiterated its "buy" rating and $40 price target for Zymeworks Inc. following the company's announcement to acquire Theravance Biopharma Inc. The acquisition, valued at approximately $929 million in equity, includes Theravance's YUPELRI product and is expected to close in the second half of 2026. Analysts from BTIG, Stifel, and H.C. Wainwright have also provided ratings and targets for both companies in light of this strategic move and recent clinical data for Zymeworks' pipeline.

American Express is actively recruiting a VP of Stablecoin & Blockchain Partnerships & Strategy, indicating a shift in its stance on stablecoins despite its CEO previously stating that existing payment rails were "not broken." The article highlights Amex's unique business model as an issuer, acquirer, and network, contrasting it with Visa and Mastercard, and points out that rewards represent a significant competitive advantage for Amex. This move suggests Amex is exploring how stablecoins could complement its current financial ecosystem, especially given their potential for cross-border payments.

Hormel Foods (NYSE: HRL) has entered into a definitive agreement to sell its Brazilian operations, operating under the CERATTI brand, to Zanchetta Alimentos LTDA. This divestiture is part of Hormel's strategy to simplify its portfolio and focus on international markets with stronger long-term growth opportunities. The transaction is expected to close in the coming weeks, subject to customary conditions and regulatory approval, with minimal impact on the company's adjusted fiscal 2026 financial results.

Rocket Lab's stock surged over 12% after announcing an $8 billion acquisition of Iridium Communications, aiming to create a vertically integrated space enterprise. This deal will combine Rocket Lab’s launch and manufacturing capabilities with Iridium's global L-band network, securing stable revenue and reducing reliance on third-party launches. The acquisition, backed by a $3.6 billion bridge loan, positions Rocket Lab as a primary commercial aerospace competitor to SpaceX, with its upcoming 'Neutron' launch vehicle expected to be a key long-term growth driver.

F5 Networks (FFIV) stock has hit an all-time high of $411.66, reflecting a 54.56% year-to-date surge. The company’s recent strategic moves include the acquisition of SurePath AI, the launch of its AI Security Platform, and a partnership with Equinix to develop a distributed AI security framework, signaling a strong focus on AI and security solutions. RBC Capital has maintained an Outperform rating and raised its price target for F5, citing its position in a hardware refresh cycle and increasing AI workloads.

AbbVie stock recently hit a new 52-week high, but despite its 40% gain over the past year, it has only risen 11% year-to-date, suggesting it hasn't become excessively expensive. Trading at less than 18 times estimated future earnings, below the S&P 500 average, and with a strong acquisition strategy (like Apogee Therapeutics) and an above-average dividend yield of 2.7%, the company is considered a solid long-term investment. The article suggests that despite the high, it's not too late to buy for long-term investors.

Hormel Foods Corporation announced it will sell its Brazilian operations, which include the Ceratti brand, to Zanchetta Alimentos LTDA. This move is part of Hormel's strategy to streamline its portfolio and concentrate on international markets with stronger long-term growth prospects. The sale is expected to have a minimal impact on Hormel's adjusted fiscal 2026 financial results, and further details will be provided during its Q3 fiscal 2026 earnings call.

Coca-Cola (KO) is shifting its growth narrative from aggressive pricing to a "balanced" approach focusing on volume and price/mix. This change coincides with the first real crack in its comparable gross margins in years, suggesting that the previous pricing power may be reaching a ceiling. Investors should monitor the gross margin line closely, as this new "balanced" strategy appears to be a less profitable reality.

Cantor Fitzgerald analyst C.J. Muse has maintained an Overweight rating for Teradyne (TER) and significantly raised its price target from $400.00 to $550.00, reflecting strong confidence in the company's future performance. Despite this, GuruFocus indicates that TER is currently 157.2% overvalued with a GF Value™ of $168.04 against its current price of $432.25, and insider activity shows $6.7 million in sales over the last three months, suggesting caution for investors. Teradyne, operating in the semiconductor testing and industrial automation sectors, exhibits strong financial health and growth potential but faces valuation concerns.